• Leading the design and execution of clinical trials specific to neurodevelopmental (FXS, Jordan’s, etc) and CNS diseases, ensuring adherence to regulatory standards and ethical guidelines.
• Developing comprehensive medical strategies tailored to address the unique challenges and considerations of rare neurodevelopmental diseases, including patient recruitment, endpoint selection, and data analysis.
• Overseeing safety monitoring activities, including the review and analysis of adverse events, safety signals, and risk management strategies specific to these diseases.
• Providing medical oversight throughout all phases of clinical development, including protocol development, site selection, patient monitoring, and data interpretation.
• Coordinating the preparation of clinical study reports, investigator brochures, and other regulatory documents relevant to clinical trials in this disease space.
• Overseeing the medical and clinical aspects of New Drug Applications and regulatory interactions globally.
• Leading the dissemination of study results through publications in peer-reviewed journals, presentations at scientific conferences, and engagement with medical and patient advocacy communities.
• Collaborating with cross-functional teams including Clinical Operations, Regulatory Affairs, Pharmacovigilance, and Medical Affairs to ensure alignment of medical objectives with broader organizational goals.
• Coordinating the preparation of clinical study reports, investigator brochures, and other regulatory documents relevant to rare disease clinical trials.
• Establishing and maintaining relationships with Key Opinion Leaders (KOLs), external experts in the field of rare diseases to gather insights, facilitate investigator-initiated studies, and advance scientific knowledge.
• Staying abreast of advancements in the field of neurodevelopmental diseases and other CNS conditions including cognitive disorders, through ongoing education, participation in scientific meetings, and engagement with professional networks to ensure the application of best practices and innovative approaches in clinical development.
• Developing and delivering educational initiatives for internal stakeholders, investigators, and patient communities to raise awareness and understanding of neurodevelopmental diseases and ongoing clinical research efforts.
• Evaluate external assets for potential in-licensing or acquisition, considering medical value, strategic alignment, and therapeutic relevance. Collaborate with business development teams to provide medical insights and support due diligence assessments.
• Conduct comprehensive evaluations of internal pipeline products, analyzing clinical data, market potential, and competitive landscape to inform strategic decisions. Provide recommendations for resource allocation, prioritization, and portfolio management to maximize asset value and strategic alignment.
• Other duties as assigned.

Minimum Job Requirements

• Medical degree (MD or equivalent) with board certification preferred.
• Minimum of 12 years of experience in clinical practice/clinical research with at least 5 years in pharmaceutical industry required; 5 years of continuous clinical development experience in neurodevelopmental diseases, serving as a medical expert/medical monitor for Phase 2 and/or Phase 3 studies, or as a clinical leader for a product in Phase 2 and/or Phase 3.
• Substantial experience in clinical development within the pharmaceutical or biotechnology industry, with a focus on neurodevelopmental diseases.
• Proven track record of successful leadership in designing and executing clinical trials for neurodevelopmental diseases, resulting in regulatory submissions and approvals.
• Strong understanding of regulatory requirements and guidelines governing rare disease drug development. Ability to write regulatory documents in clear language.
• Thorough knowledge of Good Clinical Practices (GCPs) and regulatory reporting requirements, particularly in the US and internationally, for product safety is necessary.
• Experience in writing and reviewing scientific and clinical research reports for regulatory submission and scientific publication is preferred.
• Excellent communication and interpersonal skills, with the ability to collaborate effectively with internal and external stakeholders.
• Demonstrated ability to think strategically, analyze complex medical data, and make informed decisions.
• Commitment to continuous learning and professional development in the field of rare diseases.

• Deep understanding of rare diseases, including their pathophysiology, natural history, and clinical manifestations, is essential. Strong clinical knowledge and experience in diagnosing and managing neurodevelopmental diseases.
• Comprehensive knowledge of drug development processes, including clinical trial design, regulatory requirements, and safety monitoring procedures specific to rare diseases. Familiarity with orphan drug regulations and incentives is also important.
• Ability to think strategically and develop comprehensive medical strategies to address the unique challenges associated with neurodevelopmental diseases. This includes identifying innovative approaches to patient recruitment, endpoint selection, and data analysis.
• Strong leadership skills are essential for guiding cross-functional teams and driving the successful execution of clinical development programs. Ability to inspire and motivate team members toward common goals.
• Excellent communication skills, both verbal and written, are crucial for effectively communicating complex medical concepts to diverse stakeholders, including internal teams, external experts, regulatory agencies, and patient advocacy groups.
• Ability to collaborate effectively with cross-functional teams, including Clinical Operations, Regulatory Affairs, Pharmacovigilance, and Medical Affairs, is essential. Ability to foster a culture of teamwork and collaboration to achieve shared objectives.
• Strong analytical and problem-solving skills are necessary for identifying and addressing challenges that arise during the clinical development process. Able to quickly analyze data, identify trends, and develop solutions to overcome obstacles.
• Committed to upholding the highest ethical standards and ensuring compliance with regulatory requirements throughout the drug development process, prioritizing patient safety and data integrity at all times.
• Ability to adapt to changing priorities, timelines, and circumstances is critical in the fast-paced environment of clinical development.
• Commitment to continuous learning and professional development is essential for staying abreast of advancements in the field of rare diseases and emerging trends in clinical research methodologies.

• This position has significant managerial and decision-making authority.
• Ability and willingness to travel approximately 25% of the year both domestically and internationally
• Must live a commutable distance to our US Corporate Headquarters in Florham Park, NJ. Office presence required at least 50% of the time per month

• Ability to travel via automobile and/or airplane.
• Ability to view video display terminal images < 18” away from face for extended period of time – up to four (4) hours at a time.
• Ability to operate a computer keyboard and telephone.
• Ability to sit for extended periods of time – up to four (4) hours at a time.
• Ability to lift, tug, pull up to fifteen (15) pounds.